These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 9768277

  • 1. [Report of drug resistance in strains of Mycobacterium tuberculosis isolated from patients in Iran].
    Bahrmand AR, Siadati A, Samar G, Sanami A.
    Rev Cubana Med Trop; 1996; 48(2):92-7. PubMed ID: 9768277
    [Abstract] [Full Text] [Related]

  • 2. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [Abstract] [Full Text] [Related]

  • 3. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

  • 4. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.
    Arch Inst Pasteur Madagascar; 2002 May; 68(1-2):44-7. PubMed ID: 12643091
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M.
    Tuberkuloza; 1966 May; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II, Shmelev EI.
    Probl Tuberk Bolezn Legk; 2004 May; (7):32-5. PubMed ID: 15379039
    [Abstract] [Full Text] [Related]

  • 8. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A.
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [Abstract] [Full Text] [Related]

  • 9. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
    Zhukova MP.
    Probl Tuberk; 1997 Oct; (5):12-5. PubMed ID: 9454239
    [Abstract] [Full Text] [Related]

  • 10. [The resistance status of Mycobacterium tuberculosis in Austria 1992 and 1993].
    Stauffer F, Jaksch G.
    Wien Klin Wochenschr; 1995 Oct; 107(15):470-1. PubMed ID: 7676686
    [Abstract] [Full Text] [Related]

  • 11. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa, Zhangireev AA, Sidorenko OA.
    Probl Tuberk Bolezn Legk; 2008 Oct; (5):20-2. PubMed ID: 18711814
    [Abstract] [Full Text] [Related]

  • 12. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran.
    Mirsaeidi MS, Tabarsi P, Farnia P, Ebrahimi G, Morris MW, Masjedi MR, Velayati AA, Mansouri D.
    Saudi Med J; 2007 Apr; 28(4):544-50. PubMed ID: 17457475
    [Abstract] [Full Text] [Related]

  • 13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 14. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A, Gogate A.
    Indian J Public Health; 1998 Mar; 42(4):126-30. PubMed ID: 10389525
    [Abstract] [Full Text] [Related]

  • 15. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA, Rusakova LI, Grigor'eva ZP, Ryzhova AP, Iatskova TV, Poluéktova FG.
    Probl Tuberk; 2001 Mar; (1):28-30. PubMed ID: 11337776
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F.
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [Abstract] [Full Text] [Related]

  • 17. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [Abstract] [Full Text] [Related]

  • 18. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF, Mariño Callejo A, Lorenzo García MV, Rodríguez Mayo M, Domínguez Gómez D, Sesma Sánchez P.
    Med Clin (Barc); 1999 Nov 06; 113(15):572-4. PubMed ID: 10605682
    [Abstract] [Full Text] [Related]

  • 19. Antituberculosis drug resistance and associated risk factors in the European section of Turkey.
    Karabay O, Otkun M, Akata F, Karlikaya C, Tuğrul M, Dündar V.
    Indian J Chest Dis Allied Sci; 2004 Nov 06; 46(3):171-7. PubMed ID: 15553205
    [Abstract] [Full Text] [Related]

  • 20. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun 06; 30(6):403-5. PubMed ID: 17673006
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.